Blocking HIV-1 Replication: Are Fc–Fcγ Receptor Interactions Required?

Journal of Clinical Investigation - United States
doi 10.1172/jci125264
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Fc or Not Fc; That Is the Question: Antibody Fc-Receptor Interactions Are Key to Universal Influenza Vaccine Design

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2017English

Rational Engineering of Fc/Fc Receptor Interactions to Improve Antibody Potency

Breast Cancer Research
Cancer ResearchOncology
2003English

The Cellular HIV-1 Rev Cofactor hRIP Is Required for Viral Replication

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Asymmetric HIV-1 Co-Receptor Use and Replication in CD4+ T Lymphocytes

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2010English

Fcγ Receptor Targeting in RA

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

Exploiting Replication Deficiencies to Illuminate HIV: Host Interactions

Retrovirology
VirologyInfectious Diseases
2011English

Interaction Between Reverse Transcriptase and Integrase Is Required for Reverse Transcription During HIV-1 Replication

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Gp120/Cd4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals

PLoS ONE
Multidisciplinary
2015English

Inhibition of HIV-1 Replication by eIF3f

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy